givinostat

FDA Drug Profile — DUVYZAT

givinostat is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including DUVYZAT. Available dosage form: suspension.

Drug details

Generic Name
givinostat
Brand Names
DUVYZAT
Application Number
NDA217865
Sponsor
Italfarmaco SPA
NDC Codes
2
Dosage Forms
SUSPENSION
Routes
ORAL
Active Ingredients
GIVINOSTAT

Indications and Usage

1 INDICATIONS AND USAGE DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.